Provided by Tiger Trade Technology Pte. Ltd.

Yesterday's Top Gainers

926.91
-5.4005-0.58%
Number of Gainers:18
Number of Losers:30
Number of Flat:7
PE:- -
High:932.16
Open:932.16
Low:914.63
Close:932.31
Volume:62.28M
Turnover:1.26B
Market Cap:162.08B
Float Cap:93.92B

Loading ...

Ethos Technologies Inc. Class A (LIFE) Gets a Buy from Barclays

TIPRANKS
·
3 hours ago

Ethos: Leading Digital Life Insurance Platform Poised for Secular Growth and Multiple Expansion

TIPRANKS
·
3 hours ago

Ethos initiated with an Overweight at Barclays

TIPRANKS
·
3 hours ago

Ethos initiated with an Outperform at Citizens

TIPRANKS
·
3 hours ago

Ethos initiated with a Buy at Goldman Sachs

TIPRANKS
·
3 hours ago

RES S.p.A. Continues Share Buyback Program on Euronext Growth Milan

TIPRANKS
·
4 hours ago

Ethos Technologies Inc.: Capitalizing on Underpenetrated Life Insurance Market with Sustained Double-Digit Growth

TIPRANKS
·
5 hours ago

Why Aehr Test Systems (AEHR) Is Up 16.5% After Landing A Major Hyperscaler AI Chip-Testing Deal – And What's Next

Simply Wall St.
·
6 hours ago

Funding Risks Put Tronox’s Long‑Term Competitiveness and Project Returns in Jeopardy

TIPRANKS
·
Yesterday

Faruqi & Faruqi Alerts Regenxbio Investors to April 14, 2026 Securities Class Action Deadline

Reuters
·
Feb 21

Kepler Capital Remains a Sell on TGS (0MSJ)

TIPRANKS
·
Feb 21

Bridgford Foods Corporation Announces Annual Shareholders Meeting

Reuters
·
Feb 21

Tronox files automatic mixed securities shelf

TIPRANKS
·
Feb 21

Helix Energy Solutions to Join NYSE Energy & Utilities Virtual Investor Access Day

Reuters
·
Feb 21

US court revives Regenxbio patent lawsuit over muscular dystrophy treatment

Reuters
·
Feb 21

Regenxbio Wins Appeal in Patent Dispute With Sarepta Therapeutics

MT Newswires Live
·
Feb 21

iRhythm should be bought on subpoena weakness, says William Blair

TIPRANKS
·
Feb 21

iRhythm Technologies Is Maintained at Outperform by Baird

Dow Jones
·
Feb 21

Court revives Regenxbio, UPenn patent suit against Sarepta, Bloomberg says

TIPRANKS
·
Feb 21

iRhythm says received civil investigative demand from DOJ in December

TIPRANKS
·
Feb 20